BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 60%* for North American Extreme

1 year 40%, 2 years 40% and *3 years 60%

*Across 3 years $4354.20.64 only $1741.68

ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
40.69
0.27%
US Tech 100
20,239.20
-0.65%
S&P 500
5,998.74
-0.38%
US Dollar vs CAD
1.40213
-0.04%
Bitcoin
95,808.08
-0.18%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Supernus Pharmaceuticals Inc (SUPN)

  7. Supernus Pharmaceuticals Inc (SUPN) Financials

Supernus Pharmaceuticals Inc

Supernus Pharmaceuticals Inc (SUPN)

NASDAQ
36.99
0.85
(2.35%)
Closed November 27 3:00PM
Delayed by 15 minutes
36.99
-0.01
(-0.03%)
After Hours: 3:47PM
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Annual Quarterly
Quarter End Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 167.84M155.41M134.77M154.34M164.52M144.74M172.68M176.71M
Operating Income 32.44M5.18M-17.59M8.14M-996k-3.15M22.57M40.85M
Pre Tax Income 35.14M9.02M-17.13M9.89M990k243k26.3M44.94M
Net Income 25.48M16.95M-831k-15.98M1.18M124k19.92M38.5M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT 32.44M5.18M-17.59M8.14M-996k-3.15M22.57M40.85M
EBITDA 53.85M25.78M3.14M30.03M40.84M17.6M43.29M60.95M
Year End December 30 2023 20162017201820192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 215M302.24M408.9M392.76M520.4M586.31M667.75M609.04M
Operating Income 54.22M99.54M144.44M148.57M173.7M86.03M46.12M-5.27M
Pre Tax Income 50.37M100.62M140.18M147.49M168.65M73.18M60.74M2.77M
Net Income 91.22M57.28M110.99M113.06M126.95M53.42M60.71M1.32M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 1.8251.1162.1222.1522.4011.0031.1190.024
EBIT 53.53M99.25M144.44M148.57M173.7M86.03M46.12M-5.27M
EBITDA 56.62M107.64M151.54M155.23M193.7M118.62M131.67M99.78M

Your Recent History

NASDAQ
SUPN
Supernus Pharmaceuticals
AQSE
LEND.GB
Sancus Lending
BIT
UC9160
Unicredit Bank
BIT
UB6JLG
Unicredit Bank
BIT
UI379C
Unicredit Bank
BIT
P1OUU8
BNP Paribas Issuance
BIT
UB6VJJ
Unicredit Bank
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 60%* for North American Extreme

1 year 40%, 2 years 40% and *3 years 60%

*Across 3 years $4354.20.64 only $1741.68